-
US Justice Dept releasing new batch of Epstein files
-
South Africa and Israel expel envoys in deepening feud
-
French eyewear maker in spotlight after presidential showing
-
Olympic dream 'not over', Vonn says after crash
-
Brazil's Lula discharged after cataract surgery
-
US Senate races to limit shutdown fallout as Trump-backed deal stalls
-
'He probably would've survived': Iran targeting hospitals in crackdown
-
Djokovic stuns Sinner to set up Australian Open final with Alcaraz
-
Mateta omitted from Palace squad to face Forest
-
Gold, silver prices tumble as investors soothed by Trump's Fed pick
-
Trump attorney general orders arrest of ex-CNN anchor covering protests
-
Djokovic 'pushed to the limit' in stunning late-night Sinner upset
-
Tunisia's famed blue-and-white village threatened after record rains
-
Top EU official voices 'shock' at Minneapolis violence
-
Kremlin says agreed to halt strikes on Kyiv until Sunday
-
Carrick calls for calm after flying start to Man Utd reign
-
Djokovic to meet Alcaraz in Melbourne final after five-set marathon
-
Italian officials to testify in trial over deadly migrant shipwreck
-
Iran says defence capabilities 'never' up for negotiation
-
UN appeals for more support for flood-hit Mozambicans
-
Lijnders urges Man City to pile pressure on Arsenal in title race
-
Fulham sign Man City winger Oscar Bobb
-
Strasbourg's Argentine striker Panichelli sets sights on PSG, World Cup
-
Jesus 'made love': Colombian president irks Christians with steamy claim
-
IAEA board meets over Ukraine nuclear safety concerns
-
Eurozone growth beats 2025 forecasts despite Trump woes
-
Israel to partially reopen Gaza's Rafah crossing on Sunday
-
Dutch PM-elect Jetten says not yet time to talk to Putin
-
Social media fuels surge in UK men seeking testosterone jabs
-
Forest face Fenerbahce, Celtic draw Stuttgart in Europa League play-offs
-
US speed queen Vonn crashes at Crans-Montana, one week before Olympics
-
Trump nominates former US Fed official as next central bank chief
-
Alcaraz defends controversial timeout after beaten Zverev fumes
-
New Dutch government pledges ongoing Ukraine support
-
Newcastle still coping with fallout from Isak exit, says Howe
-
Chad, France eye economic cooperation as they reset strained ties
-
Real Madrid to play Benfica, PSG face Monaco in Champions League play-offs
-
Everton winger Grealish set to miss rest of season in World Cup blow
-
Trump brands Minneapolis nurse killed by federal agents an 'agitator'
-
Arteta focuses on the positives despite Arsenal stumble
-
Fijian Drua sign France international back Vakatawa
-
Kevin Warsh, a former Fed 'hawk' now in tune with Trump
-
Zverev rails at Alcaraz timeout in 'one of the best battles ever'
-
Turkey leads Iran diplomatic push as Trump softens strike threat
-
Zelensky backs energy ceasefire, Russia bombs Ukraine despite Trump intervention
-
'Superman' Li Ka-shing, Hong Kong billionaire behind Panama ports deal
-
Skiing great Lindsey Vonn crashes at Crans-Montana, one week before Olympics
-
Slot warns Liverpool 'can't afford mistakes' in top-four scrap
-
Paris show by late Martin Parr views his photos through political lens
-
'Believing' Alcaraz outlasts Zverev in epic to reach maiden Melbourne final
| RBGPF | 1.65% | 83.78 | $ | |
| SCS | 0.12% | 16.14 | $ | |
| RYCEF | -2.69% | 16 | $ | |
| NGG | -0.33% | 84.77 | $ | |
| CMSC | -0.02% | 23.69 | $ | |
| AZN | 0.38% | 92.94 | $ | |
| GSK | 1.03% | 51.18 | $ | |
| BP | 0.09% | 38.075 | $ | |
| BTI | -0.47% | 59.93 | $ | |
| RIO | -3.08% | 92.29 | $ | |
| VOD | -0.55% | 14.63 | $ | |
| BCE | 0.1% | 25.51 | $ | |
| JRI | 0.23% | 12.985 | $ | |
| BCC | -1.31% | 79.132 | $ | |
| RELX | -1.25% | 35.72 | $ | |
| CMSD | 0.05% | 24.073 | $ |
Dispense Times Releases New Issue Featuring Mark Cuban, Offering Clarity for Independent Pharmacy Owners
New January-February Edition Highlights Transparent Insights on Cost Plus Drugs and the Future of Community Pharmacy
PITTSBURGH, PENNSYLVANIA / ACCESS Newswire / January 21, 2026 / Dispense Times, a leading digital publication serving independent pharmacy owners across the United States, has released its latest January-February issue, featuring an in-depth article with Mark Cuban that helps clear up widespread misconceptions surrounding Cost Plus Drugs and its role within the pharmacy ecosystem.
As conversations around alternative drug pricing models continue to gain attention, this issue was developed to provide pharmacy owners with accurate, fact-based context. The featured article focuses on education and transparency, helping independent pharmacists better understand how emerging models intersect with - and differ from - traditional community pharmacy operations.
"This issue was created to inform, not inflame," said the Dispense Times editorial team. "Independent pharmacy owners deserve clear, honest insight - especially when high-profile healthcare discussions dominate headlines and social media."
Industry-Wide Contributions
This issue of Dispense Times includes contributions from pharmacy owners, healthcare professionals, and industry leaders from across the country. Each article reflects real-world experience and practical insight into the challenges, opportunities, and innovations shaping independent pharmacy today.
"With PBM reform gaining momentum and national exposure, Mark Cuban's consistent advocacy and work with 'Mark Cuban Cost Plus Drug's' means the public is paying more attention to the complex issues of pharmacy benefit managers. This issue of Dispense Times highlights Cuban's knowledge of the traditional 3-big PBMs and will help to accelerate meaningful change to medication access and affordability." - stated Todd Eury, founder of the Pharmacy Podcast Network and the 'Pharmacy 50 Awards' which Cuban was voted as the 19th most influential person in pharmacy.
Dispense Times sincerely thanks all contributing authors for sharing their expertise and helping advance informed discussion within the profession.
Thank You to Our Sponsors
- Pharmacy Podcast Network
- Mark Cuban Cost Plus Drugs
- Lansworth Pharma SelfServe
- Atrium24
- Shepard Medical Products
- Little Miracle Pain Spray
- Infowerks
- Waypoint
- Pharmacy Marketplace
- Pharmacists United for Truth and Transparency
- Suncrest
- Capital Drug
Read the Full Issue
The complete January-February issue of Dispense Times is available online and can be read here:
https://heyzine.com/flip-book/a18c487a24.html
Media Contact
Todd Eury
CEO at RxPR, LLC.
[email protected]
(412) 585-4001
About Dispense Times
Dispense Times is a digital magazine dedicated to supporting independent pharmacies through education, industry insights, and advocacy. With a growing national readership, Dispense Times serves as a trusted voice for pharmacy owners navigating an evolving healthcare landscape.
SOURCE: Dispense Times
View the original press release on ACCESS Newswire
W.Morales--AT